Evidence map›Paper›PMID 30774776›Full record

ArticleOncotarget2019

Contribution of

Silvia Juliana Trujillo-Cáceres, Luisa Torres-Sánchez, Ana I Burguete-García, Yaneth Citlalli Orbe Orihuela, Ruth Argelia Vázquez-Salas, Esmeralda Álvarez-Topete, Rocío Gómez

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Silvia Juliana Trujillo-CáceresCentro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública (INSP), Cuernavaca, Morelos, Mexico.
Luisa Torres-SánchezCentro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública (INSP), Cuernavaca, Morelos, Mexico.
Ana I Burguete-GarcíaCentro de Investigación en Enfermedades Infecciosas, INSP, Cuernavaca, Morelos, Mexico.
Yaneth Citlalli Orbe OrihuelaCentro de Investigación en Enfermedades Infecciosas, INSP, Cuernavaca, Morelos, Mexico.
Ruth Argelia Vázquez-SalasConacyt-Centro de Investigación en Salud Poblacional, INSP, Cuernavaca, Morelos, Mexico.
Esmeralda Álvarez-TopeteDepartamento de Toxicología, Cinvestav-IPN, Mexico City, Mexico.
Rocío GómezDepartamento de Toxicología, Cinvestav-IPN, Mexico City, Mexico.
Instituto Nacional de Salud Pública · MXCenter for Research and Advanced Studies of the National Polytechnic Institute · MXInstituto Politécnico Nacional · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sexually transmitted infections and its contribution to prostate cancer (PC) development have been relevant in different populations.

Indexed as

genetic polymorphismsMSMBprostate cancerrs10993994sexually transmitted diseases

Identifiers

PMID30774776
PMCPMC6366823
OpenAlexW2914420307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.